DoorDash stock slides nearly 4% as Feb. 18 earnings date nears and CEO sale shows up in filings

DoorDash stock slides nearly 4% as Feb. 18 earnings date nears and CEO sale shows up in filings

New York, January 9, 2026, 14:34 EST — Regular session

DoorDash (DASH.O) shares were down about 3.8% at $215.66 in afternoon trade on Friday, after earlier touching $224.80. The stock was $8.44 below its previous close.

The retreat comes as investors turn to DoorDash’s next results for clues on how fast spending is rising in 2026 and whether growth is cooling. DoorDash, Inc. said on Wednesday it will release fourth-quarter and full-year 2025 results after U.S. markets close on Feb. 18. 1

A conference call will follow at 5 p.m. ET. Traders expect management to spend much of the time on investment levels and execution overseas, not just order trends. 2

An SEC filing showed Chief Executive Tony Xu exercised options for 16,667 shares at $7.16 and sold 16,667 shares at $230, roughly $3.83 million, on Jan. 5. It said the sale was made under a Rule 10b5-1 plan — a pre-arranged trading program — adopted on March 8, 2025. 3

DoorDash completed its acquisition of Britain’s Deliveroo in October, adding the London-based app’s nine-country footprint to its own operations. 4

In its last quarterly update, the company said it would invest “several hundred million dollars more” in 2026 than in 2025 on new initiatives, a stance that has divided investors between growth and margin. 5

DoorDash earns fees on each order and pays couriers per delivery, which means promotions and driver incentives can swing profit even when demand looks steady. Uber’s Eats unit and Instacart remain key rivals in food and grocery delivery.

But the stock can still lurch on softer consumer spending, higher fuel and labor costs, or fresh rules that force platforms to treat more couriers as employees. Any stumble in integrating acquired businesses would add pressure.

The next clear catalyst is Feb. 18, when DoorDash is due to post results after the closing bell. Investors will be listening for how long the company expects the heavier 2026 build-out to last. 6

Stock Market Today

BBAI stock jumps 16% into BigBear.ai share-vote week — what to watch next

BBAI stock jumps 16% into BigBear.ai share-vote week — what to watch next

7 February 2026
New York, Feb 7, 2026, 08:52 EST — Market closed. BigBear.ai Holdings, Inc (NYSE: BBAI) shares jumped 15.7% on Friday to close at $4.72, a sharp bounce that put the small-cap AI and defense contractor back on traders’ screens heading into the new week. 1 The move matters now because BigBear.ai is closing in on a shareholder vote that would let it roughly double the number of shares it is allowed to issue — a step that can make it easier to raise cash, pay for deals, or grant stock awards, but can also dilute existing holders. The company has
American Airlines stock jumps nearly 8% as airlines rally — what to watch next week

American Airlines stock jumps nearly 8% as airlines rally — what to watch next week

7 February 2026
American Airlines shares jumped 7.6% to $15.24 Friday, rebounding with a broad rally that sent the Dow past 50,000 for the first time. Investors are watching the carrier’s battle with United at Chicago O’Hare, where a summer capacity surge could trigger a fare war. American also announced new Philadelphia–Porto service for 2027 and launched a centennial inflight menu.
Apple stock price ends week higher as Dow hits 50,000; jobs and CPI loom next

Apple stock price ends week higher as Dow hits 50,000; jobs and CPI loom next

7 February 2026
Apple closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. The S&P 500 jumped 1.97% and the Nasdaq rose 2.18% as chipmakers rallied, while Amazon fell 5.6% on higher capex guidance. Investors await U.S. jobs data Feb. 11 and CPI Feb. 13. Apple’s next dividend is $0.26 per share, payable Feb. 12.
Uber stock slides nearly 3% as CES robotaxi push puts costs back in focus
Previous Story

Uber stock slides nearly 3% as CES robotaxi push puts costs back in focus

Johnson & Johnson stock slips on Trump drug-price pact as tariff relief comes into view
Next Story

Johnson & Johnson stock slips on Trump drug-price pact as tariff relief comes into view

Go toTop